Ann: Appendix 4C and Business Update, page-6

I agree, the sales seem to be heading in the right direction and there is a clear use case for the product from a health and economic perspective. Hopefully it's just a matter of time before they can reach enough scale to break even. Just depends on whether they run out of cash on the way and need a further CR. If the options are all exercised then I would think they'll be well funded - but of course that's a lot of dilution too at 1.4cents.